Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma: Comparison of Two Established Schedules

NCT04019262 is registered in ClinicalTrials.gov with John Flickinger as lead sponsor.

NCT NCT04019262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04019262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma: Comparison of Two Established Schedules
Lead sponsor
John Flickinger
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
December 14, 2021
Completion date
July 31, 2027
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma